Abstract:Objective: The present study aimed to establish a prognostic signature based on the autophagy-related long non-coding RNAs (lncRNAs) analysis in patients with hepatocellular carcinoma (HCC). Methods: Patients with HCC from The Cancer Genome Atlas (TCGA) were taken as the training cohort, and patients from the International Cancer Genome Consortium (ICGC) were treated as the validation cohort. Autophagy-related lncRNAs were obtained via a co-expression network analysis. According to univariate and multivariate analyses, a multigene prognostic signature was constructed in the training cohort. The predictive power of the signature was confirmed in both cohorts. The detailed functions were investigated using functional analysis. The single-sample gene set enrichment analysis (ssGSEA) score was used to evaluate the tumor microenvironment. The expression levels of immunotherapy and targeted therapy targets between the two risk groups were compared. Finally, a nomogram was constructed by integrating clinicopathological parameters with independently predictive value and the risk score. Results: Four autophagy-related lncRNAs were identified to establish a prognostic signature, which separated patients into high- and low-risk groups. Survival analysis showed that patients in the high-risk group had a shorter survival time in both cohorts. A time-independent receiver-operating characteristic (ROC) curve and principal component analysis (PCA) confirmed that the prognostic signature had a robust predictive power and reliability in both cohorts. Functional analysis indicated that the expressed genes in the high-risk group are mainly enriched in autophagy- and cancer-related pathways. ssGSEA revealed that the different risk groups were associated with the tumor microenvironment. Moreover, the different risk groups had positive correlations with the expressions of specific mutant genes. Multivariate analysis showed that the risk score also exhibited excellent predictive power irrespective of clinicopathological characteristics in both cohorts. A nomogram was established. The nomogram showed good discrimination, with Harrell's concordance index (C-index) of 0.739 and good calibration. Conclusion: The four autophagy-related lncRNAs could be used as biological biomarkers and therapeutic targets. The prognostic signature and nomogram might aid clinicians in individual treatment optimization and clinical decision-making for patients with HCC.

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma

Transcriptomic Model-Based Lncrnas and Mrnas Serve As Independent Prognostic Indicators in Head and Neck Squamous Cell Carcinoma

An Autophagy-related Long Non-coding RNA Prognostic Signature for Laryngeal Squamous Cell Carcinoma

An Autophagy-Related Long Noncoding RNA Signature Contributes to Poor Prognosis in Colorectal Cancer

Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma

Prognostic Significance of an Autophagy-Related Long Non-Coding RNA Signature in Patients with Oral and Oropharyngeal Squamous Cell Carcinoma.

Development and validation of prognostic index based on autophagy-related genes in patient with head and neck squamous cell carcinoma

An Autophagy-Related Long Non-Coding RNA Prognostic Signature for Patients with Lung Squamous Carcinoma Based on Bioinformatics Analysis

Identification of Three Autophagy-Related Long Non-Coding RNAs As a Novel Head and Neck Squamous Cell Carcinoma Prognostic Signature

Development and Validation of a Prognostic Signature Based on Autophagy-related Long Non-coding RNA Analysis in Hepatocellular Carcinoma

Signature Based on Six Autophagy-related Genes to Predict Prognosis of Head and Neck Squamous Cell Carcinoma

A Three-Long Non-Coding RNA Signature Derived from the Cancer Genome Atlas Database Predicts the Survival of Patients with Head and Neck Squamous Cell Carcinoma

An autophagy-associated lncRNAs model for predicting the survival in non-small cell lung cancer patients

The Prognostic Value of an autophagy-related lncRNA Signature in Esophageal Cancer

Identification of hub lncRNAs in head and neck cancer based on weighted gene co-expression network analysis and experiments

Author Response for "identification of Autophagy-Related Gene and Lncrna Signatures in the Prognosis of HNSCC"

Development and Validation of a Prognostic Signature Associated With Tumor Microenvironment Based on Autophagy-Related lncRNA Analysis in Hepatocellular Carcinoma

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma

A Three-Lncrna Signature Derived from the Atlas of Ncrna in Cancer (TANRIC) Database Predicts the Survival of Patients with Head and Neck Squamous Cell Carcinoma.

Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases

A Prognostic 5-Lncrna Expression Signature for Head and Neck Squamous Cell Carcinoma.